jCyte's Grant

jCyte raised a round of funding on January 05, 2017. Investors include California Institute of Regenerative Medicine.

jCyte is developing jCell, an effective stem cell therapy for retinitis pigmentosa (RP). It uses retinal progenitor cells (RPCs) to rescue diseased retinal cells and possibly regenerate new ones. This…

Articles about jCyte's Grant: